1 Clinical Evaluation of ABS: Diagnostic Considerations Carl N. Kraus, M.D. Medical Officer Division of Special Pathogen and Immunologic Drug Product Office.

Slides:



Advertisements
Similar presentations
Infection in COPD Pulmonology Subspeciality Rounds (12/11/2008)Dr.Krock Dr.Vysetti Dr.Vysetti.
Advertisements

Acute Otitis Media Trials: Evolution of Guidance Janice Soreth, M.D. Division of Anti-Infective Drug Products January 30, 2001.
Sinusitis By Emilie Watson.
Upper Respiratory Tract Infections Dr. Meenakshi Aggarwal MD Emory Family Medicine.
Severity of Disease, Radiographic Presentation, and Outcomes in Ten Adult Patients with Mycoplasma pneumoniae Pneumonia: Results from the Rapid Empiric.
Michael De Vito M.D. Capital Region Otolaryngology Group
Clinical Trial Design in Acute Bacterial Sinusitis Considerations for Future Guidance Clinical Trial Design in Acute Bacterial Sinusitis Considerations.
Role of MRSA Swabs for De-escalation of Antibiotics in HCAP
In the name of God. HEADACHE AND ENT PROBLEMS ► Abtahi S.Hamidreza MD. ► Otolaryngologist ► Kashan Univercity Of Medical Science.
1 Issues in Selection of Deltas in Non-Inferiority Trials : Acute Bacterial Meningitis and Hospital- Acquired Pneumonia John H. Powers, M.D. Medical Officer.
Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Microbiologic Surrogates: An Industry Perspective Barry Eisenstein, MD Senior Vice President, Research and Development Cubist Pharmaceuticals Clinical.
Chronic Sinusitis.
Microbiologic Surrogate Endpoints in Clinical Trials-IDSA FDA/IDSA/ISAP Workshop April 15, 2004 Sheldon L. Kaplan, MD Baylor College of Medicine Texas.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2010.
AAP Clinical Practice Guideline: Management of Sinusitis Pediatrics 108:798, 2001 (Sep)
Office of Drug Evaluation IV, CDER FDA/IDSA/ISAP Workshop 4/16/04 Overview of PK-PD in Drug Development Programs: FDA Perspective FDA/IDSA/ISAP Workshop.
Surrogate Endpoints in Infectious Diseases Trials: FDA Perspective Surrogate Endpoints in Infectious Diseases Trials: FDA Perspective John H. Powers, MD.
1 Catheter-Related Bloodstream Infection Guidance Revisited Janice Pohlman, M.D. FDA AIDAC Presentation October 14, 2004.
Moustapha Mounib Senior Consultant of Chest Diseases Military Medical Academy.
Do not use this guideline Individualize patient evaluation for excluded groups Patients with symptoms concerning for complications: Periorbital cellulitis.
Objectives Upon completion of the lecture, students should be able to:  Define middle ear infection  Know the classification of otitis media (OM). 
Definitions  Middle ear is the area between the tympanic membrane and the inner ear including the Eustachian tube.  Otitis media (OM) is inflammation.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Antibiotic Use in URTI Gary Kroukamp ENT Specialist Kingsbury Hospital.
Grand Rounds Rebecca Burton-MacLeod R4, Emergency Medicine February 1 st, 2007.
Design of Clinical Trials of Antibiotic Therapy for Acute Otitis Media
RHINOSINUSITIS DANIEL W. TODD, M.D. MIDWEST ENT FORM AND FUNCTION FORM (ANATOMY)FUNCTION (PHYSIOLOGY)
32 yo woman with sinusitis Started with runny nose, cough, and sore throat 10 days ago Developed nasal congestion and drainage 1 day later On day 6 seen.
1 Selection of  in Clinical Trials of Antimicrobial Therapy - Acute Exacerbation of Chronic Bronchitis Susan D. Thompson, M.D. February 19, 2002.
Design of Clinical Trials of Antibiotic Therapy for Acute Otitis Media
Neonates (children less than one month of age) have immature immune systems and are at higher risk for serious complications of bacterial and viral infections,
Journal Club Usha Niranjan SPR Paediatrics/ Diabetes & Endocrine.
Acute Bacterial Rhinosinusitis. Brief Background Typically follows viral infection Dx is by clinical manifestations Streptococcus pneumoniae, Haemophilus.
Bacterial Meningitis Linnea Giovanelli.
Sex-Specific Chest Pain Characteristics in AMI Jay Mansfield, Pgy-3 July 22, 2014 LSU Journal Club Gimenez, M, et. Al. Jama Int Med. 2014;174(2):
Development of Antibiotics for Otitis Media: Past, Present, and Future Janice Soreth, M.D. Director Division of Anti-Infective Drug Products.
Clinical Trials Considerations in Primary Bacteremia due to Staphylococcus aureus Clinical Trials Considerations in Primary Bacteremia due to Staphylococcus.
Copyright restrictions may apply Intranasal Midazolam vs Rectal Diazepam for the Home Treatment of Acute Seizures in Pediatric Patients With Epilepsy Holsti.
INTRODUCTION Upper respiratory tract infections, including acute pharyngitis, are common in general practice. Although the most common cause of pharyngitis.
Peritonsillar Abscess: I&D vs Needle Aspiration Mandisa McIver, MD Cohen Children’s Medical Center of New York Pediatric Emergency Medicine.
Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology.
Measuring Effectiveness in Trials of Acute Bacterial Sinusitis Measuring Effectiveness in Trials of Acute Bacterial Sinusitis John H. Powers, MD Lead Medical.
1 Observations from Past Approvals for Acute Bacterial Sinusitis Janice Pohlman, M.D. AIDAC Meeting, October 29, 2003.
SCH Journal Club Use of time from fever onset improves the diagnostic accuracy of C-reactive protein in identifying bacterial infections Wednesday 13 th.
Group A streptococcal (GAS) pharyngitis: food-borne outbreak
Acute Otitis Media: Lessons Learned Thomas Smith, M.D. Division of Anti-Infective Drug Products.
Catheter-Related Blood Stream Infections A Phase 2 Randomized, Controlled Trial of Dalbavancin vs. Vancomycin Tim Henkel, MD, PhD Executive VP and Chief.
Acute Bacterial Otitis Media Summary and Charge to the Committee Renata Albrecht, M.D. Division of Special Pathogen and Immunologic Drug Products ODEIV,
Sinusitis Dr.Emamzadegan Ped.Cardiologist. Sinusitis Sinusitis is a common illness of childhood and adolescence.
Sinusitis By: Ashley and Ally.
Journal Club Management of Appendicitis
Is a Strategy Based on Routine Endotracheal Cultures the Best Way to Prescribe Antibiotics in Ventilator-Associated Pneumonia? CHEST 2013; 144(1):63-71.
Tigecycline use in serious nosocomial infections: a drug use evaluation Matteo Bassetti*, Laura Nicolini, Ernestina Repetto, Elda Righi, Valerio Del Bono,
IDSA CLINICAL PRACTICE GUIDELINE FOR ACUTE BACTERIAL RHINOSINUSITIS IN CHILDREN AND ADULTS CLINICAL INFECTIOUS DISEASES ADVANCE ACCESS PUBLISHED MARCH.
Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Johannes M.A. Daniels; Dominic snijders;
An Inflammatory condition involving the paranasal sinuses and linings of the nasal passages that lasts 12 week or longer This diagnosis requires objective.
Copyright © 1999 American Medical Association. All rights reserved.
Adenoiditis.
Diagnostic Accuracy of Acute Streptococcal Pharyngo-tonsillitis using the Centor Score Among Adults in the Malaysian Local Primary Care Setting to Improve.
Reference Article.
Fever in infants: Evaluation by
Pre-treatment SNOT-22 Score Predicts Response to Endoscopic Polypectomy in Clinic (EPIC) Duplicating the Response for Endoscopic Sinus Surgery Caulley.
MICROBIOLOGY OF MIDDLE EAR INFECTION (OTITIS MEDIA)
Chronic sinusitis Prof. Ehab Taha Yaseen.
Microbiology of Middle Ear Infections
MICROBIOLOGY OF MIDDLE EAR INFECTION (OTITIS MEDIA)
Diagnosis of CRS. Evaluating the Latest Data in Medical Management of Chronic Rhinosinusitis.
Presentation transcript:

1 Clinical Evaluation of ABS: Diagnostic Considerations Carl N. Kraus, M.D. Medical Officer Division of Special Pathogen and Immunologic Drug Product Office of Drug Evaluation IV Center for Drug Evaluation and Research U.S. Food and Drug Administration

2 Although common, it is difficult to differentiate bacterial sinusitis from other causes of acute sinusitis

3 (+) Imaging (+) Symptoms Which individuals have bacteria in their sinuses? Need for Population Definition Need for Population Definition Enriched population with greatest potential to benefit from antimicrobial therapy (+) Culture

What evidence is present in the literature correlating specific diagnostic criteria for individuals that have acute bacterial sinusitis (ABS)?

5 Criteria Evaluated 1.Symptom Duration 2.Symptom Characteristics 3.Radiography 4.Endoscopy

6 Search Strategy Sought studies that specified inclusion criteria and had a sinus puncture with culture as part of the initial evaluation. Illness duration at time of inclusion Illness duration at time of inclusion Antimicrobial use prior to study inclusion Antimicrobial use prior to study inclusion Percent of patients that underwent sinus puncture Percent of patients that underwent sinus puncture Study population Study population Use of a microbiologic cutoff Use of a microbiologic cutoff Specified inclusion criteria (signs, symptoms, radiography) Specified inclusion criteria (signs, symptoms, radiography)

7 General Search Methodology MeSH Search 1966 to Present KeywordSearch Article References Abstract Evaluation Full Article Review

8 Studies Identified  Symptom duration: 0 studies identified  Symptom character: 5 studies identified  Radiography:12 studies identified  Endoscopy:2 studies identified

9 Approaches to Population Enrichment 1. Symptom Duration 2. Symptom Characteristics 3. Radiography 4. Endoscopy

10 1. Symptom Duration Symptoms thought to be related to viral rhinosinusitis typically have a median duration of 1 week Gwaltney et.al., JAMA. 1967;202(6): % of patient with the common cold have (+) CT. Gwaltney et. al., NEJM, 1994; 330:25-30 Bacterial sinusitis is seen in only 20% of patients with symptoms less than 7 days Comments in Hickner JM et. al., Ann Intern Med. 2001;134(6): No studies evaluating the timing of sinus taps and microbiology identified in the literature.

11 Approaches to Population Enrichment 1. Symptom Duration 2. Symptom Characteristics 3. Radiography 4. Endoscopy

12 Reporting Variations Patient Based Reporting Sinus Based Reporting Sinus Based Reporting Aspirate Based Reporting 30 patients 15 with (+) cultures 50% (+) Culture Rate 30 patients 60 sinus punctures 40 (+) cultures 67% (+) Culture Rate 30 patients 80 sinus aspirates 60 (+) cultures 75% (+) Culture Rate

13 Symptom Characteristics (2) 34% 1 60% 2 65% 3 1 van Buchem L, Eur J Gen Pract, : Hamory, B.H., et al., J Infect Dis, (2): Savolainen, S., et al., Acta Otolaryngol Suppl, : p Berg O, et. al., Scand J Infect Dis 20: , % 4 Inclusion: “clinical symptoms and signs of sinusitis indicating diagnostic and therapeutic puncture” and “prevailing antral secretion at aspiration” Headache Nasal Symptoms Purulence Facial Pain Post Nasal Drip Upper Jaw Pain Nasal Obstruction Impaired Smell (+) Sinus Cultures (N=113) (N=81) (N=132)

14 Symptom Characteristics (4) 1 other study identified (24 adult pts, 17 with acute symptoms) Specific signs/symptoms not provided but: “ quality, radiation, intensity of facial pain, purulence of nasal discharge or presence of fever did not accurately predict the presence of infection as determined by aspiration” Evans FO et. al., NEJM 293: , 1975

15 Symptom Characteristics (3) No maximum symptom duration cutoff No maximum symptom duration cutoff No minimum duration of symptoms No minimum duration of symptoms No exclusion secondary to antimicrobial use No exclusion secondary to antimicrobial use patient based reporting of data patient based reporting of data 4% patients enrolled but not punctured 4% patients enrolled but not punctured (+) maximum symptom duration cutoff (+) maximum symptom duration cutoff No minimum duration of symptoms No minimum duration of symptoms Sinus based reporting of data Sinus based reporting of data 4% patients enrolled but not punctured 4% patients enrolled but not punctured No maximum symptom duration cutoff No maximum symptom duration cutoff No minimum duration of symptoms No minimum duration of symptoms Patient based reporting of data Patient based reporting of data 18% patients enrolled but not punctured 18% patients enrolled but not punctured Van Buchem N=113 Hamory N=105 (81 subjects) SavolainenN=132

16 Approaches to Population Enrichment 1. Symptom Duration 2. Symptom Characteristics 3. Radiography 4. Endoscopy

17 Radiography (1) The percentage of subject with sinus puncture cultures ranged from %.The percentage of subject with sinus puncture cultures ranged from %. Extreme heterogeneity of clinical inclusions criteria.Extreme heterogeneity of clinical inclusions criteria.

18 Radiography (2) No antibiotic exclusion No antibiotic exclusion many patients with confounding illnessesmany patients with confounding illnesses No duration cutoff No duration cutoff 4 studies (adult) 4 studies (adult) 2 sinus based reporting 2 sinus based reporting 2 patient based reporting 2 patient based reporting InclusionsReporting (+) Sinus Cultures: 30-54% Antila, J., J. Suonpaa, and O.P. Lehtonen,. Acta Otolaryngol Suppl, : Johnson, P.A., et al., J Otolaryngol, (1): p Pahor, A.L, Ear Nose Throat J, (10): p Talbot, G.H., et al., Clin Infect Dis, (10): p

19 Radiography (2)  Facial Pain  (+) antibiotic exclusion  (+) purulence  No duration cutoff  3 studies (adult)  3 sinus based reporting  0 patient based reporting InclusionsReporting (+) Sinus Cultures: % Penttila, M., et al., Acta Otolaryngol Suppl, : p Camacho, A.E., et al., Am J Med, (3): p Hamory, B.H., et al., J Infect Dis, (2):

20 Radiography (2)  radiographic criteria  (+) antibiotic exclusion  (+) use of microbiologic cutoff  duration cutoff in 1 subgroup InclusionsReporting (+) Sinus Cultures: %  3 studies (2 pediatric)  2 patient based reporting  1 sinus based reporting Wald, E.R., et al.,. N Engl J Med, (13): p Wald, E.R., et al., J Pediatr, (2): p Rantanen, T, et al, Acta Otolaryngol, (1): p

21 Radiography (4) 34 culture positive sinuses: 16/34 (47%) Air Fluid Level 10/34 (29%)opacity 8/34 (24%)mucosal thickening Hamory, B.H., et al., J Infect Dis, (2): p

22 Radiography (6) Only 1 study identified with sinus puncture data and CT: Requirments for study entry: Clinical Impression 174 subjects completed study 122 with abnormal CTs 92 subjects met CT criteria for Acute Sinusitis 61 found to have pathogenic bacteria (61/92; 66%) Hansen, J.G., et al., BMJ, (6999): p

23 Approaches to Population Enrichment 1. Symptom Duration 2. Symptom Characteristics 3. Radiography 4. Endoscopy

24 Endoscopy (1) Talbot, G.H., et al., Clin Infect Dis, (10): Vogan, J.C. et.al. Otolaryngol Head Neck Surg, (3): ProcedurePopulation N Vogan, 2000endoscopyadult13* Talbot, 2001endoscopyadult53** *13 patients, 16 sinuses; 13 sinuses with previous antibiotic use, diagnositic criteria for acute sinusitis not stated, only patients with AFL on radiography included, no dilutions noted on semiquantitative microbiology **symptoms at time of inclusion well described, patients with >5mm or AFL included, (+) minimum symptom duration noted, (+) antimicrobial exclusion, (+) chronic sinusitis exclusion, (+) dilutions noted on semiquantative microbiology

25 Endoscopy (2) No minimum duration of symptoms sinus punctures (+) in 14/16 sinuses only 4/16 sinuses (+) with more stringent micro cutoff Only 2 endoscopic cultures with > 1+ bacteria Overall, 8/16 (50%) sinuses studied had (+) endoscopic cultures with the same pathogen as the sinus puncture. (including any colony count and the pathogens S. pnemoniae, M. catarrhalis, and H. influenzae) No minimum duration of symptoms 23/46 (50%) with (+) sinus punctures 31/46 (67%) patients with (+) endoscopy Overall, 12/31 (39%) patients with (+) endoscopy had sinus puncture (+) cultures with the same pathogen. (including any colony count and the pathogens S. pnemoniae, M. catarrhalis, and H. influenzae) Vogan Talbot

26Conclusions(1) Does the literature adequately describe specific criteria for the diagnosis of ABS ?  Symptom duration: 0 studies identified  Symptom character: 5 studies identified 60-65% (2 studies)  Radiography:12 studies identified 30-77% (12 studies)  Endoscopy:2 studies identified 39-50% (2 studies) 39-50% (2 studies)

27 Symptoms Radiography Culture Symptoms are necessary, but not sufficient for ABS diagnosis.Symptoms are necessary, but not sufficient for ABS diagnosis. Radiography is not necessary or sufficient but may help enrich a population for ABS.Radiography is not necessary or sufficient but may help enrich a population for ABS. Given symptoms, cultures are sufficient and, since there is no validated, or reproducible, or standardized surrogate in the literature, necessary.Given symptoms, cultures are sufficient and, since there is no validated, or reproducible, or standardized surrogate in the literature, necessary. Conclusions (2)